Alpine Immune Sciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ALPN Nasdaq 8731 https://www.alpineimmunesciences.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alpine Immune Sciences Inc

Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy? - Apr 18th, 2024 12:30 pm
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock - Apr 15th, 2024 1:15 pm
Could This Stock Be the Next Biotech Buyout? - Apr 13th, 2024 9:29 am
Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex - Apr 12th, 2024 4:36 pm
Health Care Roundup: Market Talk - Apr 12th, 2024 2:55 pm
These Stocks Moved the Most Today: CarMax, Apple, Fastenal, Rivian, Alpine Immune, Nike, Robinhood, Constellation Brands, and More - Apr 11th, 2024 8:43 pm
Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal - Apr 11th, 2024 8:29 pm
Alpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy It - Apr 11th, 2024 8:18 pm
Stocks to Watch Thursday: Robinhood, Alpine Immune, Constellation Brands - Apr 11th, 2024 5:59 pm
Vertex Pharmaceuticals Seeks a Second Act With Alpine Immune Deal. What Wall Street Says. - Apr 11th, 2024 3:03 pm
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today - Apr 11th, 2024 1:47 pm
These Stocks Are Moving the Most Today - Apr 11th, 2024 1:47 pm
Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer - Apr 11th, 2024 1:39 pm
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion - Apr 10th, 2024 9:47 pm
Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal - Apr 10th, 2024 8:19 pm
UPDATE 3-Vertex Pharma bets on kidney disease treatment with $4.9 bln Alpine Immune deal - Apr 10th, 2024 8:16 pm
Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy - Apr 10th, 2024 8:15 pm
Vertex Enters Into Agreement to Acquire Alpine Immune Sciences - Apr 10th, 2024 8:01 pm
Vertex to buy kidney disease drugmaker Alpine for $4.9B - Apr 10th, 2024 5:34 pm
Alpine Immune Sciences (ALPN) Moves 10.4% Higher: Will This Strength Last? - Apr 9th, 2024 1:23 pm